How did ChenMed go from a single physician practice to 60 clinics in 8 states, all while treating a small population segment?

President of New Markets and Chief Growth Officer, ChenMed
Partner, Health & Life Sciences, Oliver Wyman

HMSA and Navvis Partner to Improve the Health of the People of Hawaii

Navvis and HMSA are ending fee-for-service and moving primary care physicians to value-based payments.

Executive Officer and President, Navvis
President and CEO, Hawaii Medical Service Association
Editor, Health & Life Sciences, Oliver Wyman

A new joint professorship to advance population health management.

Dean, Jefferson College of Population Health
Executive Officer and President, Navvis
Partner, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Partner, Health & Life Sciences, Oliver Wyman

Voice recognition devices like Amazon's Alexa, who already knows so much about our daily lives, may bridge precision medicine's past and future.

Program Director, Masters of Science in Management of Health Informatics & Analytics, The George Washington University

Insights in your inbox

Subscribe

Partners Sam Glick and Sven-Olaf Vathje write in Harvard Business Review on how countries around the world can learn from a broken American healthcare system.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

What some of healthcare’s most influential voices had to say about the past, present, and future of the industry on the Summit's final day.

In this curated list, find our best reads, podcasts and more from leading voices in the healthcare industry.

Learn how Alignment Healthcare is disrupting population health management with a care model rooted in analytics and based on collaboration.

CEO, Alignment Healthcare

New analysis details how far ‘all in’ provider organizations have to go to reap risk rewards.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More